Marie le, MD
Transplant Surgery · Bronx, NYNPI 1740402023
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by Intuitive Surgical at 55.4% of the total. Reporting peaked in 2023 at $739 and has fallen 52.5% since, to $351 in 2025. That places this record below the midpoint for transplant surgery clinicians in NY, where the typical reported total is $1,271.
Across 17 payments — averaging $82.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$780
- AbbVie$179
- Paragonix Technologies, Inc.$164
- Sanofi-aventis U.S. LLC$146
- Medtronic$48
- Calliditas Therapeutics US Inc.$28
- plus $63 from 3 others
Across 2 payments — averaging $159.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Transmedics, Inc.$318
What the payments were for
- Travel & lodging$73952%
- Food & beverage$66848%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $780 |
| AbbVie | 3 | $179 |
| Paragonix Technologies, Inc. | 1 | $164 |
| Sanofi-aventis U.S. LLC | 1 | $146 |
| Medtronic | 1 | $48 |
| Calliditas Therapeutics US Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Convatec Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$619
- KidneyVault$164
- THYMOGLOBULIN$146
- Mavyret$125
How this compares
$1,407 in reported general payments places this provider in the 50th percentile of 72 transplant surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atovaquone | 15 | $4,167 |
| Valganciclovir Hcl | 18 | $2,410 |
| Famotidine | 30 | $85 |
| Tamsulosin Hcl | 16 | $67 |
| Easy Touch Alcohol Prep PadsAlcohol Antiseptic Pads | 11 | $39 |
| Atorvastatin Calcium | 13 | $24 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Bronx
- Juan RoccaBronx$11K
- Milan KinkhabwalaBronx$5K
- Roberto Hernandez AlejandroRochester$524K
- Tejinder SinghAlbany$513K
- Kishore IyerNew York$95K
- Jason HawksworthNew York$91K
- Parissa TabrizianNew York$74K
- Koji TomiyamaRochester$36K
- Lloyd RatnerNew York$32K
- Hautien LiouNew York$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.